Jan 11, 2020 · As Ebola outbreaks are relatively rare and unpredictable in nature, and due to limited vaccine quantities, the Ervebo vaccine is reserved for outbreak response to protect …

Jan 24, 2020 · 8 In addition to the two candidate vaccines described above, more recently two other Ebola vaccine programmes have met the initially proposed pre-clinical trial criteria. …

The vaccine was developed during the West Africa Ebola epidemic of 2014-2016, during which more than 11 000 people lost their lives to the disease. The vaccine was tested in European …

Apr 20, 2023 · WHO prequalifies Ebola vaccine, paving the way for its use in high-risk countries. Good outbreak control relies on applying a package of interventions, including case …

Nov 12, 2019 · The injectable Ebola vaccine, Ervebo, is manufactured by Merck (known as MSD outside the US and Canada). It has been shown to be effective in protecting people from the …

Oct 18, 2019 · The World Health Organization (WHO) welcomes the European Medicines Agency (EMA) announcement recommending a conditional marketing authorization for the rVSV …

The unprecedented scale and severity of the EVD epidemic in West Africa in 2014–2016 led to calls for the urgent development and licensing of an Ebola vaccine. A considerable amount of …

Feb 3, 2025 · Likewise for treatments, approved treatments are only available for Ebola virus. The vaccine for the trial was recommended by the independent WHO candidate vaccine …

Jan 12, 2021 · The Ebola vaccine is reserved for outbreak response to protect people at the highest risk of contracting Ebola – including healthcare and frontline workers. “This is an …

Since the establishment of ICG Ebola mechanism in 2021, a total 7,370 doses of Ervebo vaccine have been approved by the ICG to respond to two EVD outbreaks in DRC. Accessing ICG …